Equity Capital And Reserves változás Dátum
AbbVie USD 12.09B 772M 2023-09
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
Acorda Therapeutics USD 67.87M 9.09M 2023-06
ALKERMES USD 1.36B 75.15M 2023-09
Amgen USD 6.23B 1.42B 2023-12
Bayer EUR 33.38B 3.57B 2023-09
Biogen USD 14.8B 315.6M 2023-12
BioMarin Pharmaceutical USD 4.95B 54.65M 2023-12
Bluebird Bio USD 222.54M 66.48M 2023-09
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Esperion Therapeutics USD -410004000 38.03M 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
Incyte USD 5.19B 258.39M 2023-12
Intra Cellular Therapies USD 591.42M 9.26M 2023-12
Marinus Pharmaceuticals USD 54.54M 2.8M 2023-09
Merck USD 41.25B 2.55B 2023-09
Moderna USD 13.85B 399M 2023-12
Neurocrine Biosciences USD 2B 149.1M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
PTC Therapeutics USD -818555000 147.74M 2023-12
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Teva Pharmaceutical Industries USD 6.93B 122M 2023-09
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
United Therapeutics USD 5.98B 272.7M 2023-12
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Biogen A Saját Tőke És A Tartalékok - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.